The mRNA or protein levels of SUMO1 were increased in several AD transgenic animal models, and SUMO-mediated alterations in specific intracellular signaling pathways contributed to AD pathologies [9,10,28]. This evidence concerns the gene SUMO1 and Alzheimer disease.